Showing results (2491-2500 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 12, 2005
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survivalGraziella Bellone, Carlo Smirne, Francesco Angelo Mauri, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2005
Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005C M Britten, C Gouttefangeas, S Kreiter
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2006
The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2Malcolm S Mitchell, Teri A Lund, Andrew K Sewell, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2006
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic cultureKlara Berencsi, Neal J Meropol, John P Hoffman, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2006
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigenSumia Ali, Kate Mulryan, Taher Taher, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Characterization and purification of a mycoplasma membrane-derived macrophage-activating factorS Caplan, R Gallily, Y Barenholz
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancerA M Nouri, R Hyde, R T Oliver
Cancer Immunology, Immunotherapy : CII|February 1, 1994
Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the antitumor action of interleukin-2A L Rakhmilevich, R J North
Cancer Immunology, Immunotherapy : CII|February 1, 1994
Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killingE Katsanis, M A Bausero, H Xu, et al.
Pageof 652